These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29935368)

  • 1. Long-term survival after partial hepatectomy for sub-stage patients with intermediate stage hepatocellular carcinoma.
    Wei WX; Yang ZS; Lu LH; Li J; Lei ZQ; Wang K; Xia Y; Yan ZL; Shen F
    Int J Surg; 2018 Aug; 56():256-263. PubMed ID: 29935368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients.
    Zhaohui Z; Shunli S; Bin C; Shaoqiang L; Yunpeng H; Ming K; Lijian L; Gang PB
    Cancer Res Treat; 2019 Jan; 51(1):65-72. PubMed ID: 29510616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.
    Kim JY; Sinn DH; Gwak GY; Choi GS; Saleh AM; Joh JW; Cho SK; Shin SW; Carriere KC; Ahn JH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Clin Mol Hepatol; 2016 Jun; 22(2):250-8. PubMed ID: 27377909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization.
    Ciria R; López-Cillero P; Gallardo AB; Cabrera J; Pleguezuelo M; Ayllón MD; Luque A; Zurera L; Espejo JJ; Rodríguez-Perálvarez M; Montero JL; de la Mata M; Briceño J
    Eur J Surg Oncol; 2015 Sep; 41(9):1153-61. PubMed ID: 26118317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomograms for Pre-operative and Post-operative Prediction of Long-Term Survival of Patients Who Underwent Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma.
    Zou Q; Li J; Wu D; Yan Z; Wan X; Wang K; Shi L; Lau WY; Wu M; Shen F
    Ann Surg Oncol; 2016 Aug; 23(8):2618-26. PubMed ID: 26903045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.
    Zhong JH; Ke Y; Gong WF; Xiang BD; Ma L; Ye XP; Peng T; Xie GS; Li LQ
    Ann Surg; 2014 Aug; 260(2):329-40. PubMed ID: 24096763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
    He CB; Lao XM; Lin XJ
    Chin J Cancer; 2017 Jul; 36(1):59. PubMed ID: 28728568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization.
    Kim JH; Shim JH; Lee HC; Sung KB; Ko HK; Ko GY; Gwon DI; Kim JW; Lim YS; Park SH
    Liver Int; 2017 Dec; 37(12):1861-1868. PubMed ID: 28581250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model prediction of long-term prognosis in patients with centrally located hepatocellular carcinoma undergoing hepatectomy.
    Yantong Y; Shan L; Zhijie C; Youwei Z
    Eur J Surg Oncol; 2018 Oct; 44(10):1595-1602. PubMed ID: 30041973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study.
    Hsu CY; Liu PH; Hsia CY; Lee YH; Nagaria TS; Lee RC; Lin HC; Huo TI
    Ann Surg Oncol; 2016 Mar; 23(3):994-1002. PubMed ID: 26487000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomograms for Pre- and Postoperative Prediction of Long-term Survival for Patients Who Underwent Hepatectomy for Multiple Hepatocellular Carcinomas.
    Yang P; Qiu J; Li J; Wu D; Wan X; Lau WY; Yuan Y; Shen F
    Ann Surg; 2016 Apr; 263(4):778-86. PubMed ID: 26135698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
    Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
    Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomograms for prediction of long-term survival in elderly patients after partial hepatectomy for hepatocellular carcinoma.
    Cheng Z; Yang P; Lei Z; Zhang B; Si A; Yan Z; Xia Y; Li J; Wang K; Hartmann D; Hüser N; Lau WY; Shen F
    Surgery; 2017 Dec; 162(6):1231-1240. PubMed ID: 29033225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis.
    Guo Z; Zhong JH; Jiang JH; Zhang J; Xiang BD; Li LQ
    Ann Surg Oncol; 2014 Sep; 21(9):3069-76. PubMed ID: 24728740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomograms to predict the long-time prognosis in patients with alpha-fetoprotein negative hepatocellular carcinoma following radical resection.
    Huang J; Liu FC; Li L; Zhou WP; Jiang BG; Pan ZY
    Cancer Med; 2020 Apr; 9(8):2791-2802. PubMed ID: 32096346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Nomogram for Hepatitis B Virus-related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection.
    Huang J; Liu FC; Li L; Yuan SX; Yang Y; Jiang BG; Liu H; Pan ZY
    Am J Clin Oncol; 2020 Jan; 43(1):20-27. PubMed ID: 31633514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the Ability of the New Subclassification to Prognosticate Outcomes Following Hepatectomy for Patients with HBV-Related HCC.
    Tian Y; Lyu H; He Y; Kanduri HK
    J Gastrointest Cancer; 2019 Sep; 50(3):400-407. PubMed ID: 29512001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.